By Jess Jones UK drug discovery company Labgenius has raised £35m in a series B funding round as it looks to ramp up its cancer treatment product pipeline. Labgenius, which is based in London’s old industrial biscuit factory in Bermondsey, plans to use the capital to expand the scope of its machine learning-driven discovery platform and progress its pipeline of drugs. M Ventures, the corporate venture capital arm of science and technology company Merck, led the funding round, alongside several existing investors and new investors Octopus Ventures and LG Corp. Dr. Oliver Hardick of M Ventures, …